co.don AG: 1st Berlin Cartilage Symposium - joint preservation comes before joint replacement for medical practitioners
(Thomson Reuters ONE) -
co.don AG /
co.don AG: 1st Berlin Cartilage Symposium - joint preservation comes before
joint replacement for medical practitioners
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Berlin / Teltow. In recent years both doctors and patients have increasingly
focused on the use of chondrocyte transplants for the treatment of articular
cartilage defects. After all, the regenerative method is an effective and gentle
form of treatment. On 9 March some 120 physicians from Germany and abroad met in
Berlin to discuss the latest developments, current methods and their experiences
of regenerative articular surgery. The symposium was chaired by Professor Mats
Brittberg (Gothenburg University, Sweden), the founder of autologous chondrocyte
transplantation, and Professor Matthias Steinwachs from the renowned Schulthess
Klinik in Zurich, Switzerland, one of the surgeons with the greatest experience
of chondrocyte transplantation.
Teltow-based co.don AG was one of the main sponsors of this expert group
meeting. "Preserving joints with the help of the body's own cells is frequently
possible much more often than doctors and patients think. With innovative
treatment methods it is vital that medical practitioners and scientists maintain
a permanent process of dialogue, which is why co.don AG is acting as the main
sponsor of this cartilage symposium", said Dr. Andreas Baltrusch, CEO of co.don
AG.
Under the scientific direction of Dr. med. Thilo John (DRK Clinic Westend) and
Dr. med. Volker Laute (Joint and Spinal Centre Steglitz), the experts discussed
cartilage surgery in a total of 16 seminars. "The Berlin Cartilage Symposium is
addressed both at colleagues who already have some experience of the topic and
those who want to get an overview of the latest cartilage therapy," explained
Dr. John. "The range of subjects stretches from the biological fundamentals of
articular cartilage via the surgical operation and post-op care through to the
financing of cell transplantations," added Dr. Laute.
In regenerative cartilage medicine the first step is to remove healthy cartilage
cells from the patient in minimally invasive surgery. These cells are then
propagated in special laboratories. The autologous cells are then inserted into
the defect, which regenerates the damaged cartilage and restores its shock-
absorbing properties. If treated early there is a very good chance of recovering
the painless joint mobility that existed previously. One of the leading European
providers of cultured chondrocyte transplants is co.don AG. The
biopharmaceutical company's method has already been used to treat more than
4,000 patients. Since 2007 the costs of treatment have been covered by statutory
German health insurance.
About co.don(®) AG:
The company is based in Teltow, Brandenburg, and was founded in 1993. Since
2001 the biopharmaceutical specialist has been listed on the Frankfurt Stock
Exchange (ISIN: DE000A1K0227). co.don AG(®) uses tissue engineering - the
cultivation and growth of autologous tissue cells - to develop innovative
products and therapeutic concepts for the orthopaedic and neurosurgical markets.
The cell-based biological drugs (autologous cell transplants for articular
cartilage and intervertebral disks) are produced without the use of antibiotics,
growth factors and genetic engineering. The Management Board of co.don(®) AG is
made up of Dr Andreas Baltrusch (CEO) and Ms Vilma Siodla (COO).
Further information is available from:
www.codon.de
http://www.berliner-knorpelsymposium.de
Press contact
BrunoMedia GmbH
Gerd J. Gauger
Bonner Straße 328
50968 Cologne
Tel: +49 (0)221 348 038 10
Fax: +49 (0)221 348 038 41
Email:codon(at)brunomedia.de
Press release (PDF):
http://hugin.info/132731/R/1593822/501609.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: co.don AG via Thomson Reuters ONE
[HUG#1593822]
Unternehmensinformation / Kurzprofil:
Datum: 14.03.2012 - 10:00 Uhr
Sprache: Deutsch
News-ID 124608
Anzahl Zeichen: 4947
contact information:
Town:
Teltow
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"co.don AG: 1st Berlin Cartilage Symposium - joint preservation comes before joint replacement for medical practitioners"
steht unter der journalistisch-redaktionellen Verantwortung von
co.don AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
